Lowering the Diagnostic Threshold for Gestational Diabetes: A Comparison of 2 Centres
Failure to optimally treat MH during pregnancy is associated with fetal overgrowth and may affect obstetrical management.
Authors
- Rachel Bond (ORCID: https://orcid.org/0000-0002-4873-3014)
- Julia Ma (ORCID: https://orcid.org/0000-0001-7010-4970)
- Katherine Mary Morrison (ORCID: https://orcid.org/0000-0002-1737-256X)
- Agnieszka Majdan
- Shaun Eintracht
- Natasha Garfield (ORCID: https://orcid.org/0009-0000-2630-8298)
- Tricia M. Peters (ORCID: https://orcid.org/0000-0002-5037-0427)
- S. J. Meltzer (ORCID: https://orcid.org/0000-0001-5126-2500)
- Kaberi Dasgupta (ORCID: https://orcid.org/0000-0002-2447-3553)
- Sanaz Azizi (ORCID: https://orcid.org/0009-0002-2617-0203)
Institutions
- McGill University Health Centre (CA)
- Jewish General Hospital (CA)
- Group for Research in Decision Analysis (CA)
- MD Precision (Canada) (CA)
- McGill University (CA)
Publication Details
- Journal
- Canadian Journal of Diabetes
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1016/j.jcjd.2025.10.176
- Primary Topic
- Gestational Diabetes Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00